Observational studyAdvances in therapy2022

XaMINA: A Real-World, Prospective, Observational Study of Treatment-Naïve Patients Treated with Rivaroxaban for Stroke Prevention in Atrial Fibrillation in Asia.

Ping-Yen Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.